High-performance liquid chromatographic analysis of dianhydrogalactitol in plasma by derivatization with sodium diethyldithiocarbamate.
A high-performance liquid chromatographic method is described for measuring submicrogram quantities of dianhydrogalactitol, a promising anti-neoplastic agent, in plasma. The drug is derivatized directly in plasma with sodium diethyldithiocarbamate to form a bis(dithiocarbamoyl) ester which absorbs UV light at 254 nm (am 17,000). The derivatized product is then extracted quantitatively into chloroform and separated by normal phase chromatography (muBondpak CN column). Dianhydrogalactitol concentration below 50 ng/ml of plasma can be detected in the eluent.
D055598:Chemical Phenomena; D002621:Chemistry; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004050:Ditiocarb; D004988:Ethers, Cyclic / Q000097:blood; D004376:Galactitol / Q000031:analogs & derivatives / Q000097:blood*; D006801:Humans; D013056:Spectrophotometry, Ultraviolet; D013402:Sugar Alcohols / Q000097:blood*
D004988:Ethers, Cyclic; D013402:Sugar Alcohols; D004376:Galactitol; D004050:Ditiocarb